financetom
Business
financetom
/
Business
/
Hubbell Q4 Adjusted EPS Rises, Net Sales Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hubbell Q4 Adjusted EPS Rises, Net Sales Decrease
Feb 4, 2025 5:22 AM

07:50 AM EST, 02/04/2025 (MT Newswires) -- Hubbell (HUBB) reported Q4 adjusted earnings Tuesday of $4.10 per diluted share, up from $3.69 a year earlier.

Analysts polled by FactSet expected $4.02.

Net sales for the quarter ended Dec. 31 were $1.33 billion, down from $1.35 billion a year earlier.

Analysts surveyed by FactSet expected $1.41 billion.

The company expects 2025 adjusted diluted EPS between $17.35 and $17.85.

Analysts polled by FactSet expect $17.75.

Hubbell shares fell 2% in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Factbox-A timeline of Trump's moves to dismantle the US wind and solar energy industries
Factbox-A timeline of Trump's moves to dismantle the US wind and solar energy industries
Aug 27, 2025
(Reuters) -U.S. President Donald Trump has used his second term in the White House to stymie development of wind and solar energy facilities that were a cornerstone of former President Joe Biden's climate and energy agendas. Here is a timeline of actions his administration has taken to unravel federal support for clean energy projects: January 20 On his first day...
Veracyte Says Gene Test Predicts Chemotherapy Benefit in Prostate Cancer Patients
Veracyte Says Gene Test Predicts Chemotherapy Benefit in Prostate Cancer Patients
Aug 27, 2025
12:12 PM EDT, 08/27/2025 (MT Newswires) -- Veracyte ( VCYT ) and University College London said that their data show Veracyte's ( VCYT ) Decipher test can help identify which prostate cancer patients might benefit from stronger chemotherapy treatment. The Decipher Prostate Genomic Classifier also predicts which patients are unlikely to benefit from treatment intensification, helping them avoid unnecessary side...
Sea Unusual Options Activity
Sea Unusual Options Activity
Aug 27, 2025
High-rolling investors have positioned themselves bearish on Sea , and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SE often signals that someone has privileged information. Today, Benzinga's options scanner spotted 12...
EQT in talks with NextDecade for LNG Supply, Bloomberg News reports
EQT in talks with NextDecade for LNG Supply, Bloomberg News reports
Aug 27, 2025
Aug 27 (Reuters) - EQT Corp ( EQT ) is in talks to take a supply of liquefied natural gas from NextDecade's ( NEXT ) export terminal, which is being built in Texas, Bloomberg News reported on Wednesday, citing people familiar with the matter. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved